Call for Abstract
9th Annual Congress on Endocrine Disorders and Therapies, will be organized around the theme “Collaborative Strategies and Innovative Approaches to fight Endocrine Disorders”
Endocrine 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Endocrine 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Endocrine system is a network of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders. Each gland of the endocrine system releases specific hormones into your bloodstream. These hormones travel through your blood to other cells and help control or coordinate many body processes.
- Track 1-1Glands of the endocrine system
- Track 1-2Symptoms and causes of endocrine disorders
- Track 1-3Different types and testing for endocrine disorders
- Track 1-4Performance enhancing drugs
- Track 1-5Bartters syndrome
- Track 1-6Advanced technologies and treatment
- Track 1-7Insulin medication
- Track 1-8Case studies
Hormones are chemical messengers that have diverse chemical structures including eicosanoids, steroids, amino acid derivatives, peptides, and proteins that are secreted into the blood, which carries them to organs and tissues of the body to exert their functions. They are essential for every activity of life, including the processes of such as digestion, metabolism, respiration, tissue function, sensory perception, sleep, excretion, lactation, stress, growth and development, movement, reproduction, and mood. Many hormones, such as neurotransmitters, are active in more than one physical process.
- Track 2-1Origin and synthesis
- Track 2-2Hormone interactions with receptors
- Track 2-3Steroids and cancer
- Track 2-4Steroids in women
- Track 2-5Hormone-dependence and metabolism
- Track 2-6Hormones and diabetes complications
Obesity is highly associated with various endocrine abnormalities that are characterized by hormonal imbalance and/or resistance. Weight reduction generally normalizes these endocrine alterations, implicating obesity as a direct cause. Being overweight or obese predisposes an individual to many medical problems including diabetes, high blood pressure, heart disease, stroke, depression and some types of cancer. In the United States, the frequency of these conditions is increasing at epidemic rates.
- Track 3-1Overweight/extreme obesity and food intake control
- Track 3-2Diet and weight management
- Track 3-3Adipocyte function and immuno metabolism
- Track 3-4Metabolic regulation in physiology and disease
- Track 3-5Genetic risk factors
- Track 3-6Treatment of obesity
- Track 3-7Drug discovery/development in obesity
Overproduction of a pituitary gland hormone leads to an overactive adrenal gland. A similar condition called Cushing's syndrome may occur in people, particularly children, who take high doses of corticosteroid medications. It is a cause of Cushing's syndrome characterized by increased secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary. This is most often as a result of a pituitary adenoma or due to excess production of hypothalamus CRH that stimulates the synthesis of cortisol by the adrenal glands. Pituitary adenomas are responsible for 80% of endogenous Cushing's syndrome, when excluding Cushing's syndrome from exogenously administered corticosteroids.
- Track 4-1Symptoms, diagnosis & treatment
- Track 4-2Hypoaldosteronism and hyperaldosteronism
- Track 4-3Pheochromocytoma/paraganglioma
- Track 4-4Hyperplasia
- Track 4-5Dexamethasone suppression test
- Track 4-6Brain MRI and lipid and cholesterol testing
- Track 4-7Inferior petrosal sinus sampling
- Track 4-8Pseudo-cushing states
Overproduction of growth hormone causes excessive growth. In children, the condition is called gigantism. In adults, it is called acromegaly. Growth hormone stimulates the growth of bones, muscles, and many internal organs. Excessive growth hormone, therefore, leads to abnormally robust growth of all of these tissues. Overproduction of growth hormone is almost always caused by a noncancerous (benign) pituitary tumor (adenoma). Certain rare tumors of the pancreas and lungs also can produce hormones that stimulate the pituitary to produce excessive amounts of growth hormone, with similar consequences.
- Track 5-1Delayed puberty
- Track 5-2McCune-Albright syndrome
- Track 5-3Carney complex
- Track 5-4Neurofibromatosis
- Track 5-5Glucose tolerance test
- Track 5-6treatment and medication
- Track 5-7Gamma knife radiosurgery
- Track 5-8Acromegaly
The thyroid gland does not produce enough thyroid hormone, leading to fatigue, constipation, dry skin, and depression. The underactive gland can cause slowed development in children. Some types of hypothyroidism are present at birth. Hypothyroidism can be treated with levothyroxine. The dose is adjusted according to symptoms and normalization of the thyroxine and TSH levels. Thyroid medication is safe in pregnancy. While a certain amount of dietary iodine is important, excessive amounts can worsen certain types of hypothyroidism.
- Track 6-1Thyroid disorder
- Track 6-2Hashimoto’s disease
- Track 6-3Grave’s disease
- Track 6-4Goiter
- Track 6-5Treatment and medication
These are rare, genetic conditions are passed down through families. They cause tumors of the parathyroid, adrenal, and thyroid glands, leading to overproduction of hormones. The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time. The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.
- Track 7-1Medullary carcinoma of thyroid
- Track 7-2Pheochromocytoma
- Track 7-3Parathyroid adenoma
- Track 7-4Parathyroid hyperplasia
- Track 7-5Treatment and medication
Overproduction of androgens interfere with the development of eggs and their release from the female ovaries. PCOS is a leading cause of infertility. Polycystic ovary syndrome is a problem in which a woman hormones are out of balance. It can cause problems with your periods and make it difficult to get pregnant. PCOS also may cause unwanted changes in the way you look. If it isn't treated, over time it can lead to serious health problems, such as diabetes and heart disease. Hormones are chemical messengers that trigger many different processes, including growth and energy production. Often, the job of one hormone is to signal the release of another hormone.
- Track 8-1Signs and symptoms
- Track 8-2Diagnosis, treatment and medication
- Track 8-3Infertility
- Track 8-4Menstrual disorders
- Track 8-5High levels of masculinizing hormones
- Track 8-6Metabolic syndrome
- Track 8-7Oligoovulation and anovulation
- Track 8-8Gynecologic ultrasonography
- Track 8-9Congenital adrenal hyperplasia
The most frequent type of pituitary disorder is a pituitary gland tumor. These tumors are fairly common in adults. They are not brain tumors and are almost always benign. Not all pituitary tumors cause symptoms. Pituitary tumors that make hormones can cause a variety of signs and symptoms depending on the hormone they produce. The signs and symptoms of pituitary tumors that don't make hormones are related to their growth and the pressure they put on other structures.
The pituitary is the "master control gland" - it makes hormones that affect growth and the functions of other glands in the body. With pituitary disorders, you often have too much or too little of one of your hormones. Injuries can cause pituitary disorders, but the most common cause is a pituitary tumor. Pituitary gland disorders can affect many different parts of the body. Conditions such as acromegaly, Cushing's syndrome, hypothyroidism, and hypogonadism all may result from pituitary gland disease.
- Track 9-1Hypopituitarism
- Track 9-2Secretory and non-secretory tumors
- Track 9-3Hypersecretion and hyposecretion
- Track 9-4Pituitary adenomas
- Track 9-5Adrenocorticotropic hormone-secreting (ACTH) tumors
- Track 9-6Growth hormone-secreting tumors
- Track 9-7Prolactin-secreting tumors
- Track 9-8Thyroid-stimulating hormone-secreting tumors
- Track 9-9Pituitary insufficiency
- Track 9-10Pituitary apoplexy
- Track 9-11Case reports
Sex hormone disorders occur when there is either an overproduction or underproduction of the hormones responsible for sexual characteristics and development. In females, the main female hormone is estrogen which is primarily produced by the ovaries. Women also produce androgens. Testosterone and DHEAS are two of the androgens women produce. When these hormones are not in balance women may experience symptoms including menstrual cycle irregularities, hirsutism, acne and alopecia. In males, the main male hormone is testosterone. When males do not produce enough testosterone they may experience a decline in libido, erectile dysfunction, loss of muscle and loss of body hair.
- Track 10-1Intersex disorders
- Track 10-2Gonadal dysgenesis
- Track 10-3Hermaphroditism and androgen insensitivity syndromes
- Track 10-4Klinefelter and kallmann syndrome
- Track 10-5Menstrual function or fertility disorders
- Track 10-6Erectile dysfunction
- Track 10-7Hypogonadism and gynecomastia
- Track 10-8Hirsutism
- Track 10-9Menopause and perimenopause
- Track 10-10Reproductive hormone disorders
- Track 10-11Ovarian insufficiency
The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. People with metabolic syndrome are twice as likely to die from, and three times as likely to have a heart attack or stroke compared with people without the syndrome. People with metabolic syndrome have a five-fold greater risk of developing type 2 diabetes. Up to 80% of the 200 million people with diabetes globally will die of cardiovascular disease. This puts metabolic syndrome and diabetes way ahead of HIV/AIDS in morbidity and mortality terms yet the problem is not as well recognised.
- Track 11-1Lipid metabolism
- Track 11-2Diabetes self-management tools
- Track 11-3New discoveries and emerging therapies for type 1 and 2 diabetes
- Track 11-4Advances and strategies in drug development
- Track 11-5Stem cell research in the diabetes space
- Track 11-6Long noncoding and microRNAs and metabolism
Hypertension is caused due to the elevation in the blood pressure levels which is defined as systolic blood pressure >140 mm Hg. Endocrine hypertension is the raise of hypertension caused by the imbalance of hormones. This frequently involves the pituitary or adrenal gland. The person who is more likely to have hypertension before the age of 30 with a strong family history of adrenal gland tumors , hypertension or develop hypokalemia should undergo endocrine hypertension screening. the endocrine hypertension can be caused due to the over or less production of hormone or when effected by tumors.
- Track 12-1Gordons syndrome
- Track 12-2Liddle syndrome
- Track 12-3Apparent mineralocorticoid excess (AME)
- Track 12-4Licorice ingestion
- Track 12-5Gitelmans syndrome
Adrenoleukodystrophy also known as ALD is a genetic disease or an inborn error of metabolism that affects 1 in 18000 people today. This is also known as X linked adrenoleukodystrophy as it is linked to x chromosome. This is a brain disorder that is caused due to the building up of fatty acids which are caused by the enzymes which do not function properly. This results in the destruction of the myelin sheath which is known as a protective sheath that surrounds the neurons in the brain. The destruction of the myelin sheath results in hyperactivity and seizures and also dyslexia. It’s a disorder of peroxisomal fatty acid beta oxidation which results in the accumulation of long fatty acid chains in the body. The adrenal cortex and leydig cells in the testes are also effected. The treatment options for ALD are very limited. Dietary therapy is done by Lorenzo oil. If the defect is spotted in the childhood treatment can be done by stem cell transplant and gene therapy.
- Track 13-1Adrenoleukodystrophy in males and females
- Track 13-2Dietary therapy
- Track 13-3Genetics of adernoleukodystrophy
- Track 13-4Case studies of adrenoleukodystrophy
Cryptorchidism is the highly common genital problem that is encountered in pediatrics. This is detected by the absence of one or both testes from the scrotum and generally refers to an undescended or maldescended testis. About 3% of full-term and 30% of premature infant boys are born with at least one undescended testis. This may develop after the infant stage or during the late adulthood ( but this is exceptional ). Cryptorchidism is a from of monorchism, the condition of having only one testicle. The condition may occur on one or both sides; it more commonly affects the right testis.. cryptorchidism nearly always refers to congenital absence or maldescent, a testis observed in the scrotum in early infancy can occasionally "reascend" into the inguinal canal.
- Track 14-1Normal fetal testicular development and descent
- Track 14-2Psychological consequences
- Track 14-3Infertility
- Track 14-4Veterinary occurrence
- Track 14-5Case study of cryptorchidism
Thyroid cancer is a tumorous condition that arises when abnormal cells begin to grow in the thyroid gland. The gland resembles a butterfly shape located infront of the neck. This is originated from follicular and parafollicular cells. This can be detected in the early stage and can be cured in the early stage. This cancer may revert back after the treatment after many years or immediately. The causes are detected as the changes in the DNA in the cells that are likely to inherit from one generation to the other generation. The malignant tumors can be removed by a process known as thyroidectomy followed by the radioactive iodine ablation and TSH suppression therapy. Chemotherapy or radiotherapy can also be done during the metastasis stage or the advanced cancer stage
- Track 15-1Papillary thyroid cancer
- Track 15-2Follicular thyroid cancer
- Track 15-3Anaplastic thyroid cancer
- Track 15-4Medullary thyroid cancer
Neuroendocrine cancer is a malignant tumour that starts in neuroendocrine cells. Neuroendocrine tumors most commonly occur in the intestine, where they are often called carcinoma tumors. Pancreatic neuroendocrine tumors form in hormone-making cells (islet cells) of the pancreas. They may or may not cause signs or symptoms. Neuroendocrine small cell cancer accounts for approximately 15% of bronchogenic carcinomas.
- Track 16-1Neuroendocrine cancer
- Track 16-2Advancements in neuroendocrinology
- Track 16-3Neuroendocrine large and small cell cancer
- Track 16-4Neuroendocrine tumors and carcinoma
- Track 16-5Neuroendocrine lung ad liver treatment
- Track 16-6Neural control of adipose/adipose function
- Track 16-7Case studies of neuroendocrine disorders